Literature DB >> 1003710

Electrical and mechanical responses to diltiazem in potassium depolarized myocardium of the guinea pig.

H Nakajima, M Hoshiyama, K Yamashita, A Kiyomoto.   

Abstract

Effects of diltiazem on the electrical and mechanical activities of guinea pig papillary muscle were investigated in K-rich Tyrode's solution (Kc1 12.7 mM). The electrical properties of cell membrane in K-rich solution were also examined in the ventricular muscle fibers. It was found that the overshoot as well as the maximum rate of rise (Vmax) of the action potential were highly sensitive to the extracellular concentration of CaC12 in K-rich solution. Vmax was also affected by NaC1. Diltiazem at a lower concentration (1.1 X 10(-7) M) caused a reduction in the contractile force of K-depolarized papillary muscle without producing significant changes in the resting and action potentials. In the presence of a higher concentration of diltiazem (1.1 X 10(-5) M), the contractile force decreased concurrently with the change in the action potential. Addition of CaC12 restored the original strength of contraction in parallel to the recovery of the action potential, especially in its overshoot and Vmax. From these results, it is inferred that diltiazem may decrease the contractile force of guinea pig papillary muscle either by interfering with the intrasmembrane calcium influx or by intracellularly reducing the free calcium ion concentration in the myoplasm.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003710     DOI: 10.1254/jjp.26.571

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  8 in total

1.  Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.

Authors:  R Okuyama; S Adachi-Akahane; T Nagao
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

Review 2.  Diltiazem.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-01

3.  Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.

Authors:  F Yoneyama; H Yamada; K Satoh; N Taira
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

Review 4.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

5.  Importance of myocardial blood flow changes in the protective action of diltiazem in a new model of myocardial ischaemia.

Authors:  L Szekeres; E Udvary; A Végh
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

6.  Further studies on the mechanism of phosphorylase activation in rabbit liver in response to splanchnic nerve stimulation.

Authors:  T Shimazu; M Usami
Journal:  J Physiol       Date:  1982-08       Impact factor: 5.182

7.  Voltage- and frequency-dependent block of diltiazem on the slow inward current and generation of tension in frog ventricular muscle.

Authors:  L Tung; M Morad
Journal:  Pflugers Arch       Date:  1983-08       Impact factor: 3.657

8.  Evidence against beta-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties.

Authors:  M Briley; I Cavero; S Z Langer; A G Roach
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.